Honors and Awards:
Boards and Certifications:
MD - 2007
Universidad Central del Caribe School of Medicine
MPH – 2002
George Washington University School of Public Health
BA – 2000
University of Michigan, Ann Arbor
Ochsner Clinic Foundation
Fellowship, Structural/Valve Interventions, 2015 – 2016
University of Florida College of Medicine at Jacksonville
Fellowship, Interventional Cardiology, 2014 – 2015
University of Puerto Rico School of Medicine
Fellowship, Cardiovascular Disease, 2010 – 2013
Harvard Medical School
Residency, Internal Medicine, 2007 – 2010
- Alpha Omega Alpha Medical Honor Society
- Fellow of American College of Cardiology
- Fellow Society of Cardiovascular Angiography and Interventions
- American Board of Internal Medicine (ABIM)
- ABIM Board Cardiovascular Diseases
- ABIM Board Interventional Cardiology
- American Board of Vascular Medicine Endovascular Medicine
- National Board of Echocardiography
Dr. Pedro Cox-Alomar is an interventional cardiologist in New Orleans, Louisiana and is affiliated with LSU Health Sciences Center. He attended and received his medical degree from Universidad Central del Caribe School of Medicine in 2007 and has been in practice for 6-10 years. He is affiliated with many hospitals including Ochsner Medical Center and University Medical Center.
Coronary Artery Disease, Complex and High Risk Coronary Interventions, Peripheral Vascular Disease, Structural Heart Disease, Endovascular interventions, Adult Congenital Heart Interventions
Machine-Learning-Based in-Hospital Mortality Prediction for Transcatheter Mitral Valve Repair in the United States. Dagmar F Hernandez-Suarez, Sagar Ranka, Yeunjung Kim, Azeem Latib, Jose Wiley, Angel Lopez-Candales, Duane S Pinto, Maday C Gonzalez, Harish Ramakrishna, Cristina Sanina, Brenda G Nieves-Rodriguez, Jovaniel Rodriguez-Maldonado, Roberto Feliu Maldonado, Israel J Rodriguez-Ruiz, Istoni da Luz Sant'ana, Karlo A Wiley, Pedro Cox-Alomar, Pedro A Villablanca, Abiel Roche-Lima
Machine Learning Prediction Models for In-Hospital Mortality After Transcatheter Aortic Valve Replacement.
Dagmar F. Hernandez-Suarez
Brenda G. Nieves-Rodriguez
Roberto Feliu Maldonado
Istoni da Luz Sant'Ana
William W. O’Neill
Duane S. Pinto
Bivalirudin versus heparin in patients undergoing percutaneous peripheral interventions: A systematic review and meta-analysis.
Olmedo W, Villablanca PA, Sanina C, Walker J, Weinreich M, Brevik J, Avendano R, Bravo CA, Romero J, Ramakrishna H, Babaev A, Attubato M, Hernandez-Suarez DF, Cox-Alomar P, Pyo R, Krishnan P, Wiley J Vascular 2018-12-01
Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
Rollini F, Franchi F, Hu J, Kureti M, Aggarwal N, Durairaj A, Park Y, Seawell M, Cox-Alomar P, Zenni MM, Guzman LA, Suryadevara S, Antoun P, Bass TA, Angiolillo DJ J Am Coll Cardiol 2016 May 3
Experience with Percutaneous Transcatheter Closure of Interatrial Communications at the Cardiovascular Center of Puerto Rico and the Caribbean.
Cox-Alomar PR, Colon-Hernandez P, Sotolongo-Fernandez A, Cox RA P R Health Sci J 2015 Sep
Association of traditional cardiovascular risk factors with coronary plaque sub-types assessed by 64-slice computed tomography angiography in a large cohort of asymptomatic subjects.
Rivera, J. J., Nasir, K., Cox, P. R., Choi, E. K., Yoon, Y., Cho, I., Chun, E. J., Choi, S. I., Blumenthal, R. S., Chang, H. J. Atherosclerosis 2009 Oct 01